Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label before-and-after study of IVIG (GGS) in multifocal motor neuropathy
jRCT2080222422Phase 3Completed
- Sponsor
- Teijin Pharma
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of subcuvia in multifocal motor neuropathy (MMN), sponsored by Teijin Pharma. Started Mar 2014; status: completed.
02
Drugs
subcuvia
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on jRCT2080222422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222422.